11 results
6-K
EX-99.1
QNTM
Quantum BioPharma Ltd
7 Nov 23
Current report (foreign)
10:30am
progressive multiple sclerosis is a course of the disease in which neurologic function worsens and disability increases, and typically follows the initial … disease course characterized by gradual worsening neurologic symptoms and an accumulation of disability. Clinically isolated syndrome, one of the 4
6-K
EX-99.1
QNTM
Quantum BioPharma Ltd
17 Apr 23
FSD Pharma Inc. 6-K
9:34am
-related); conditions associated with advanced disability and immobility (e.g., aspiration pneumonia, chronic respiratory disease). According
6-K
EX-99.4
QNTM
Quantum BioPharma Ltd
23 May 22
Annual General Meeting of the Shareholders
4:29pm
" means a director of the Corporation from time to time.
1.4.13 "Disability" means:
(a) subject to (b) below, a Participant's physical or mental … of the Corporation, in respect of which the Participant commences receiving, or is eligible to receive, disability benefits under the Corporation's
20-F
EX-4.16
l5osn82vw9tl846yhzx
31 Mar 22
Annual report (foreign)
8:09am
20-F
EX-4.17
lxx4tyx5qwx 5cpzi
31 Mar 22
Annual report (foreign)
8:09am
20-F
EX-4.2
hd5c751986s6umx20 s8
31 Mar 22
Annual report (foreign)
8:09am
6-K
EX-99.1
uwkt9s6v0qqxhmw
21 Sep 21
THIS AGREEMENT made as of the 25th day of August, 2021
4:02pm
40FR12B
EX-99.9
4v0k6yf9cdo 2ubrk9y
6 Dec 19
Initial registration of securities (Canada)
12:28pm
40FR12B
EX-99.11
dtupbf
6 Dec 19
Initial registration of securities (Canada)
12:28pm
- Prev
- 1
- Next